+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Muellerian inhibiting substance reduction of colony growth of human gynecologic cancers in a stem cell assay



Muellerian inhibiting substance reduction of colony growth of human gynecologic cancers in a stem cell assay



Gynecologic Oncology 22(2): 135-148



Muellerian Inhibiting Substance (MIS), a fetal testicular product that causes regression of the Muellerian duct in the male mammalian embryo, was evaluated for its antitumor effect on the premise that a substance active against this genital precursor in the fetus might also be active against tumors derived from these tissues. Increasingly pure fractions of biologically active MIS, prepared from newborn calf testes, were tested in the soft agar colony inhibition assay against single cell suspensions of fresh tumors derived in ascitic or solid form from patients with gynecologic malignancies. Twenty-eight tumor specimens placed in soft agar culture have provided sufficient growth to assess an MIS effect. Twenty-five of these 28 tumors showed significant colony inhibition after incubation with MIS. Increased antitumor response correlated with increased purification of MIS when the same tumor was treated with preparations of different purity. Samples obtained from the same patient at different times, from both ascites and solid tumor sources, produced nearly identical responses to MIS. MIS preparations, previously shown to be active in microcytotoxicity and colony inhibition assays against established human ovarian and endometrial carcinoma lines demonstrate consistent antitumor activity against fresh human gynecologic cancers removed at surgery.

Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 005940235

Download citation: RISBibTeXText

PMID: 3932140


Related references

Involution of the muellerian duct under the influence of the muellerian inhibiting substance in an organ culture assay. Anatomical Record 193(3): 657-658, 1979

The binding of muellerian inhibiting substance mis and growth hormone gh on chick muellerian duct md corresponds to ductal regression and growth. Journal of Cell Biology 105(4 Part 2): 12A, 1987

Programmed cell death in the muellerian duct induced by muellerian inhibiting substance. American Journal of Anatomy 149(3): 353-376, 1977

Insensitivity of the chick embryo muellerian duct to human recombinant muellerian inhibiting substance. Journal of Molecular Endocrinology 8(1): 73-78, 1992

Antibody against avian muellerian inhibiting substance mis recognizes mis on rat muellerian duct and human tumor cells. Proceedings of the National Science Council Republic of China Part B Life Sciences 13(4): 267-275, 1989

Human muellerian inhibiting substance inhibits tumor growth in vitro and in vivo. Cancer Research 51(8): 2101-2106, 1991

Mullerian inhibiting substance inhibits colony growth of a human ovarian carcinoma cell line. Journal of Clinical Endocrinology and Metabolism 54(5): 1051-1055, 1982

Muellerian inhibiting substance mis blocks autophosphorylation of the egf receptor a possible molecular mechanism of action of mis as an inhibitor of tumor cell growth. Investigational New Drugs: 90, 1987

A graded organ culture assay for the detection of muellerian inhibiting substance. Journal of Surgical Research 23(2): 141-148, 1977

Muellerian inhibiting substance inhibition of a human endometrial carcinoma cell line xeno grafted in nude mice. Gynecologic Oncology 17(1): 124-132, 1984

The correlation of glycolization in muellerian inhibiting substance and its activity for muellerian duct regression. Journal Of Cell Biologypart 2: 38a, 1983

Colony formation of solid tumors in in vitro colony assay (human tumor stem cell assay). Gan to Kagaku Ryoho. Cancer and ChemoTherapy 9(12): 2128-2132, 1982

The presence of Muellerian inhibiting substance in human seminal plasma. Human Reproduction 11(10): 2165-2169, 1996

Isolation of the bovine and human genes for muellerian inhibiting substance and expression of the human gene in animal cells. Cell 45(5): 685-698, 1986

Muellerian inhibiting substance blocks autophosphorylation of the egf receptor by inhibiting tyrosine kinase. Molecular & Cellular Endocrinology 49(1): 75-86, 1987